Trials / Completed
CompletedNCT05051813
The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 151 (actual)
- Sponsor
- Heidelberg Engineering GmbH · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess corneal epithelial thickness parameters with the ANTERION
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ANTERION | 3 repeat measurements on each of the 3 ANTERION devices and 3 reference devices. |
Timeline
- Start date
- 2021-09-07
- Primary completion
- 2024-02-28
- Completion
- 2024-12-16
- First posted
- 2021-09-21
- Last updated
- 2025-01-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05051813. Inclusion in this directory is not an endorsement.